Nanometric gold in cancer nanotechnology: Current status and future prospect

Journal of Pharmacy and Pharmacology

Volumn 65, Issue 5, 2013, Pages 634-651

  Ahmad, Mohammad Zaki ^a   Akhter, Sohail ^b   Rahman, Ziyaur ^c   Akhter, Shabib ^d   Anwar, Mohammed ^b   Mallik, Neha ^b   Ahmad, Farhan Jalees ^b  

^a Dreamz College of Pharmacy   (India)

^b HAMDARD UNIVERSITY   (India)

^c TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^d NAJRAN UNIVERSITY   (Saudi Arabia)

Author keywords

gold nano oncology; gold nanometric; nanoheater; photothermal effect; theranostic

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; ASCORBIC ACID; CETRIMIDE; CETUXIMAB; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; FLUORESCEIN ISOTHIOCYANATE; GOLD NANOPARTICLE; MACROGOL; NANOCAGE; NANOMATERIAL; NANOROD; NANOSHELL; NANOSPHERE; NANOSTAR; PHOTOSENSITIZING AGENT; PHTHALOCYANINE ALUMINUM; POLYACRYLIC ACID; POLYSTYRENESULFONIC ACID; SILICON DIOXIDE; SILVER NITRATE; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CANCER THERAPY; COLON CARCINOMA; COLORECTAL CANCER; CONTRAST ENHANCEMENT; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG RELEASE; DRUG TARGETING; HUMAN; HYPERTHERMIC THERAPY; LIGHT ABSORPTION; LIVER CANCER; NANOTECHNOLOGY; NONHUMAN; OPTICAL COHERENCE TOMOGRAPHY; PARTICLE SIZE; PHOTOACOUSTIC TOMOGRAPHY; PHOTODYNAMIC THERAPY; PHOTOTHERAPY; PROSTATE CANCER; REVIEW; SQUAMOUS CELL CARCINOMA; THERAPY EFFECT; TUMOR ABLATION; TUMOR CELL DESTRUCTION;

ANTINEOPLASTIC AGENTS; DRUG DELIVERY SYSTEMS; GOLD; HOT TEMPERATURE; HUMANS; LIGHT; NANOPARTICLES; NANOTECHNOLOGY; NEOPLASMS;

EID: 84876482636     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/jphp.12017     Document Type: Review

References (109)

1. Ahmad MZ, et al. Metallic nanoparticles: technology overview & drug delivery applications in oncology. Expert Opin Drug Deliv 2010; 7: 927-942.
2. Akhter S, et al. Cancer targeted metallic nanoparticle: targeting overview, recent advancement and toxicity concern. Curr Pharm Des 2011; 17: 1834-1850.
3. Akhter S, et al. Gold nanoparticles in theranostic oncology: current state-of-the-art. Expert Opin Drug Deliv 2012; 9: 1225-1243.
4. Rahman M, et al. Advancement in multifunctional nanoparticles for the effective treatment of cancer. Expert Opin Drug Deliv 2012; 9: 367-381.
5. van Vlerken LE, et al. Multi-functional polymeric nanoparticles for tumour-targeted drug delivery. Expert Opin Drug Deliv 2006; 3: 205-216.
6. Nune SK, et al. Nanoparticles for biomedical imaging. Expert Opin Drug Deliv 2009; 6: 1175-1194.
7. Arias JL,. Advanced methodologies to formulate nanotheragnostic agents for combined drug delivery and imaging. Expert Opin Drug Deliv 2011; 8: 1589-1608.
8. Fricker SP,. Medical uses of gold compounds: past, present and future. Gold Bull 1996; 29: 53-60.
9. Tiekink ERT,. Gold compounds in medicine: potential anti-tumour agents. Gold Bull 2003; 36: 117-124.
10. Mahdihassan S,. Cinnabar-gold as the best alchemical drug of longevity, called makaradhwaja in India. Am J Chin Med 1985; 13: 93-108.
11. Hutter E, et al. Exploitation of localized surface plasmon resonance. Adv Mater 2004; 16: 1685-1706.
12. Patra CR, et al. Fabrication and functional characterization of gold nanoconjugates for potential application in ovarian cancer. J Mater Chem 2010; 20: 547-554.
13. Patra CR, et al. Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer. Adv Drug Deliv Rev 2010; 62: 346-361.
14. Curley SA, et al. Noninvasive radiofrequency field-induced hyperthermic cytotoxicity in humancancer cells using cetuximab-targeted gold nanoparticles. J Exp Ther Oncol 2008; 7: 313-326.
15. Mukherjee P, et al. Gold nanoparticles bearing functional anti-cancer drug and anti-angiogenic agent: a '2 in 1' system with potential application in cancer therapeutics. J Biomed Nanotech 2005; 1: 224-228.
16. Mukherjee P, et al. Antiangiogenic properties of gold nanoparticles. Clin Cancer Res 2005; 11: 3530-3534.
17. El-Sayed IH, et al. Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles. Cancer Lett 2006; 239: 129-135.
18. Hirsch LR, et al. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc Natl Acad Sci U S A 2003; 100: 13549-13554.
19. O'Neal DP, et al. Photothermal tumour ablation in mice using near infrared-absorbing nanoparticles. Cancer Lett 2004; 209: 171-176.
20. Loo C, et al. Nanoshell-enabled photonics-based imaging and therapy of cancer. Technol Cancer Res Treat 2004; 3: 33-40.
21. Huang X, et al. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J Am Chem Soc 2006; 128: 2115-2120.
22. Takahashi H, et al. Gold nanorod-sensitized cell death: microscopic observation of single living cells irradiated by pulsed near-infrared laser light in the presence of gold nanorods. Chem Lett 2006; 35: 500-501.
23. Rothen-Rutishauser BM, et al. Interaction of fine particles and nanoparticles with red blood cells visualized with advanced microscopic techniques. Environ Sci Technol 2006; 40: 4353-4359.
24. Huang X, et al. Cancer cells assemble and align gold nanorods conjugated to antibodies to produce highly enhanced, sharp, and polarized surface Raman spectra: a potential cancer diagnostic marker. Nano Lett 2007; 7: 1591-1597.
25. Huff TB, et al. Hyperthermic effects of gold nanorods on tumour cells. Nanomedicine 2007; 2: 125-132.
26. Black KC, et al. Gold nanorods targeted to delta opioid receptor: plasmon-resonant contrast and photothermal agents. Mol Imaging 2008; 7: 50-57.
27. Dickerson EB, et al. Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice. Cancer Lett 2008; 269: 57-66.
28. Kawano T, et al. PNIPAM gel-coated gold nanorods, for targeted delivery responding to a near-infrared laser. Bioconjug Chem 2009; 20: 209-212.
29. von Maltzahn G, et al. Computationally guided photothermal tumor therapy using long circulating gold nanorod antennas. Cancer Res 2009; 69: 3892-3900.
30. Yi DK, et al. Matrix metalloproteinase sensitive gold nanorod for simultaneous bioimaging and photothermal therapy of cancer. Bioconjug Chem 2010; 21: 2173-2177.
31. Huang X, et al. A reexamination of active and passive tumor targeting by using rod-shaped gold nanocrystals and covalently conjugated peptide ligands. ACS Nano 2010; 4: 5887-5896.
32. Li JL, et al. Surface plasmonic gold nanorods for enhanced two-photon microscopic imaging and apoptosis induction of cancer cells. Biomaterials 2010; 31: 9492-9498.
33. Chen CL, et al. In situ real-time investigation of cancer cell photothermolysis mediated by excited gold nanorod surface plasmons. Biomaterials 2010; 31: 4104-4112.
34. Gormley AJ, et al. Biological evaluation of RGDfK-gold nanorod conjugates for prostate cancer treatment. J Drug Target 2011; 19: 915-924.
35. Choi WI, et al. Tumour regression in vivo by photothermal therapy based on gold nanorod- loaded, functional nanocarriers. ACS Nano 2011; 5: 1995-2003.
36. Kirui DK, et al. PAA-derived gold nanorods for cellular targeting and photothermal therapy. Macromol Biosci 2011; 11: 779-788.
37. Agarwal A, et al. Remote triggered release of doxorubicin in tumours by synergistic application of thermosensitive liposomes and gold nanorods. ACS Nano 2011; 5: 4919-4926.
38. Huang P, et al. Folic acid-conjugated silica-modified gold nanorods for X-ray/CT imaging-guided dual-mode radiation and photo-thermal therapy. Biomaterials 2011; 32: 9796-9809.
39. Gormley AJ, et al. Gold nanorod mediated plasmonic photothermal therapy: a tool to enhance macromolecular delivery. Int J Pharm 2011; 415: 315-318.
40. Jang B, et al. Gold nanorod-photosensitizer complex for near-infrared fluorescence imaging and photodynamic/photothermal therapy in vivo. ACS Nano 2011; 225: 1086-1094.
41. Black KC, et al. Polydopamine-enabled surface functionalization of gold nanorods for cancer cell-targeted imaging and photothermal therapy. Nanomedicine (Lond) 2012; doi: 10.2217/nnm.12.82.
42. Book Newell B, et al. Multifunctional gold nanorod theragnostics probed by multi-photon imaging. Eur J Med Chem 2012; 48: 330-337.
43. Rejiya CS, et al. Laser immunotherapy with gold nanorods causes selective killing of tumour cells. Pharmacol Res 2012; 65: 261-269.
44. Wang J, et al. Selective photothermal therapy for breast cancer with targeting peptide modified gold nanorods. Dalton Trans 2012; 41: 11134-11144.
45. Chen J, et al. Gold nanocages: bioconjugation and their potential use as optical imaging contrast agents. Nano Lett 2005; 5: 473-477.
46. Chen J, et al. Immuno gold nanocages with tailored optical properties for targeted photothermal destruction of cancer cells. Nano Lett 2007; 7: 1318-1322.
47. Kim C, et al. In vivo molecular photoacoustic tomography of melanomas targeted by bioconjugated gold nanocages. ACS Nano 2010; 4: 4559-4564.
48. Au L, et al. Quantifying the cellular uptake of antibody-conjugated Au nanocages by two-photon microscopy and inductively coupled plasma mass spectrometry. ACS Nano 2010; 4: 35-42.
49. Wang Y, et al. Evaluating the pharmacokinetics and in vivo cancer targeting capability of au nanocages by positron emission tomography imaging. ACS Nano 2012; 6: 5880-5888.
50. Fales AM, et al. Silica-coated gold nanostars for combined surface-enhanced Raman scattering (SERS) detection and singlet-oxygen generation: a potential nanoplatform for theranostics. Langmuir 2011; 27: 12186-12190.
51. Van de Broek B, et al. Specific cell targeting with nanobody conjugated branched gold nanoparticles for photothermal therapy. ACS Nano 2011; 5: 4319-4328.
52. Yuan H, et al. Gold nanostars: surfactant-free synthesis, 3D modelling, and two-photon photoluminescence imaging. Nanotechnology 2012; 23: 075102.
53. Yuan H, et al. In vivo particle tracking and photothermal ablation using plasmon-resonant gold nanostars. Nanomedicine 2012; xx: 1-9.
54. Yuan H, et al. TAT peptide-functionalized gold nanostars: enhanced intracellular delivery and efficient NIR photothermal therapy using ultralow irradiance. J Am Chem Soc 2012; 134: 11358-11361.
55. Loo C, et al. Immunotargeted nanoshells for integrated cancer imaging and therapy. Nano Lett 2005; 5: 709-711.
56. Jain PK, et al. Calculated absorption and scattering properties of gold nanoparticles of different size, shape, and composition: applications in biological imaging and biomedicine. J Phys Chem B 2006; 110: 7238-7248.
57. Ji X, et al. Bifunctional gold nanoshells with a superparamagnetic iron oxide-silica core suitable for both MR imaging and photothermal therapy. J Phys Chem C Nanomater Interfaces 2007; 111: 6245-6251.
58. Stern JM, et al. Selective prostate cancer thermal ablation with laser activated gold nanoshells. J Urol 2008; 179: 748-753.
59. Liu SY, et al. In vitro photothermal study of gold nanoshells functionalized with small targeting peptides to liver cancer cells. J Mater Sci Mater Med 2010; 21: 665-674.
60. Melancon MP, et al. Targeted multifunctional gold-based nanoshells for magnetic resonance-guided laser ablation of head and neck cancer. Biomaterials 2011; 32: 7600-7608.
61. Fekrazad R, et al. Treatment of oral squamous cell carcinoma using anti-HER2 immunonanoshells. Int J Nanomedicine 2011; 6: 2749-2755.
62. Wu C, et al. A gold nanoshell with a silica inner shell synthesized using liposome templates for doxorubicin loading and near-infrared photothermal therapy. Int J Nanomedicine 2011; 6: 807-813.
63. Xie H, et al. Effect of intratumoral administration on biodistribution of 64Cu-labeled nanoshells. Int J Nanomedicine 2012; 7: 2227-2238.
64. Xie H, et al. In vivo PET imaging and biodistribution of radiolabeled gold nanoshells in rats with tumor xenografts. Int J Pharm 2010; 395: 324-330.
65. You J, et al. Effective photothermal chemotherapy using doxorubicin-loaded gold nanospheres that target EphB4 receptors in tumors. Cancer Res 2012; 72: 4777-4786.
66. Liu H, et al. Size dependent cellular uptake, in vivo fate and light-heat conversion efficiency of gold nanoshells on silica nanorattles. Nanoscale 2012; 4: 3523-3529.
67. Xia Y, et al. Gold nanocages: from synthesis to theranostic applications. Acc Chem Res 2011; 44: 914-924.
68. Weissleder R,. A clearer vision for in vivo imaging. Nat Biotechnol 2001; 19: 316-317.
69. Cobley CM, et al. Gold nanostructures: a class of multifunctional materials for biomedical applications. Chem Soc Rev 2011; 40: 44-56.
70. Jain PK, et al. Noble metals on the nanoscale: optical and photothermal properties and some applications in imaging, sensing, biology, and medicine. Acc Chem Res 2008; 41: 1578-1586.
71. Huang X, et al. Plasmonic photothermal therapy (PPTT) using gold nanoparticles. Lasers Med Sci 2008; 23: 217-228.
72. Burda C, et al. Chemistry and properties of nanocrystals of different shapes. Chem Rev 2005; 105: 1025-1102.
73. Murphy CJ, et al. Chemical sensing and imaging with metallic nanorods. Chem Commun 2008; 5: 544-557.
74. Stone J, et al. Jackson Wright D. Biological applications of gold nanorods. Wiley. Interdiscip Rev Nanomed Nanobiotechnol 2011; 3: 100-109.
75. Gans R,. Form of ultramicroscopic particles of silver. Ann Phys 1915; 47: 270-284.
76. Huang X, et al. Gold nanoparticles: optical properties and implementations in cancer diagnosis and photothermal therapy. J Adv Res 2010; 1: 13-28.
77. Alkilany AM, et al. Gold nanorods: their potential for photothermal therapeutics and drug delivery, tempered by the complexity of their biological interactions. Adv Drug Deliv Rev 2012; 64: 190-199.
78. Daniel MC, et al. Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. Chem Rev 2004; 104: 293-346.
79. Murphy CJ, et al. Anisotropic metal nanoparticles: synthesis, assembly, and optical applications. J Phys Chem B 2005; 109: 13857-13870.
80. Murphy CJ, et al. Gold nanoparticles in biology: beyond toxicity to cellular imaging. Acc Chem Res 2008; 41: 1721-1730.
81. El-Sayed MA,. Some interesting properties of metals confined in time and nanometer space of different shapes. Acc Chem Res 2001; 34: 257-264.
82. Huang X, et al. Gold nanorods: from synthesis and properties to biological and biomedical applications. Adv Mater 2009; 21: 4880-4910.
83. Song KH, et al. Near-infrared gold nanocages as a new class of tracers for photoacoustic sentinel lymph node mapping on a rat model. Nano Lett 2009; 9: 183-188.
84. Au L, et al. Gold nanocages for cancer imaging and therapy. In:, Grobmyer SR, Moudgil BM, eds. Cancer Nanotechnology, Methods in Molecular Biology 624. New York: Humana Press, 2010: 83-100.
85. Cobley CM, et al. Targeting gold nanocages to cancer cells for photothermal destruction and drug delivery. Expert Opin Drug Deliv 2010; 7: 577-587.
86. Guerrero-Martínez A, et al. Nanostars shine bright for you Colloidal synthesis, properties and applications of branched metallic nanoparticles. Curr Opin Colloid Interface Sci 2011; 16: 118-127.
87. Yu YY, et al. Gold nanorods: electrochemical synthesis and optical properties. J Phys Chem B 1997; 101: 6661-6664.
88. Kim F, et al. Photochemical synthesis of gold nanorods. J Am Chem Soc 2002; 124: 14316-14317.
89. Martin BR, et al. Orthogonal self-assembly on colloidal gold-platinum nanorods. Adv Mater 1999; 11: 1021-1025.
90. Tong L, et al. Gold nanorods mediate tumour cell death by compromising membrane integrity. Adv Mater 2007; 19: 3136-3141.
91. Lu F, et al. Gold nanoparticles for diagnostic sensing and therapy. Inorg Chim Acta 2012; 393: 142-153.
92. Dreaden EC, et al. The golden age: gold nanoparticles for biomedicine. Chem Soc Rev 2012; 41: 2740-2779.
93. Cheng Y, et al. Deep penetration of a PDT drug into tumors by noncovalent drug-gold nanoparticle conjugates. J Am Chem Soc 2011; 133: 2583-2591.
94. Zharov VP, et al. Photothermal nanotherapeutics and nanodiagnostics for selective killing of bacteria targeted with gold nanorods. Biophys J 2006; 90: 619-627.
95. Pissuwon D, et al. Targeted destruction of murine macrophage cells with bioconjugated gold nanorods. J Nanopart Res 2007; 9: 1109-1124.
96. Gormley AJ, et al. Guided delivery of polymer therapeutics using plasmonic photothermal therapy. Nano Today 2012; 7: 158-167.
97. Lin KY, et al. Gold nanorod photothermal therapy in a genetically engineered mouse model of soft tissue sarcoma. Nano Life 2010; 1: 277-287.
98. Sun Y, et al. Template-engaged replacement reaction: a one-step approach to the large-scale synthesis of metal nanostructures with hollow interiors. Nano Lett 2002; 2: 481-485.
99. Cang H, et al. Gold nanocages as contrast agents for spectroscopic optical coherence tomography. Opt Lett 2005; 30: 3048-3050.
100. Skrabalak SE, et al. Facile synthesis of Ag nanocubes and Au nanocages. Nat Protoc 2007; 2: 2182-2190.
101. Skrabalak SE, et al. Gold nanocages for cancer detection and treatment. Nanomedicine (Lond) 2007; 2: 657-668.
102. Yang X, et al. Photoacoustic tomography of a rat cerebral cortex in vivo with au nanocages as an optical contrast agent. Nano Lett 2007; 7: 3798-3802.
103. Skrabalak SE, et al. Gold nanocages: synthesis, properties, and applications. Acc Chem Res 2008; 41: 1587-1595.
104. Au L, et al. A quantitative study on the photothermal effect of immuno gold nanocages targeted to breast cancer cells. ACS Nano 2008; 2: 1645-1652.
105. Chen J, et al. Gold nanocages as photothermal transducers for cancer treatment. Small 2010; 6: 811-817.
106. Young JK, et al. Tunable nanostructures as photothermal theranostic agents. Ann Biomed Eng 2012; 40: 438-459.
107. Bardhan R, et al. Theranostic nanoshells: from probe design to imaging and treatment of cancer. Acc Chem Res 2011; 44: 936-946.
108. Morton JG, et al. Nanoshells for photothermal cancer therapy. In:, Grobmyer SR, Moudgil BM, eds. Cancer Nanotechnology: Methods and Protocols. London: Humana Press, 2010: 101-118.
109. Park J, et al. Intra-organ biodistribution of gold nanoparticles using intrinsic two-photon induced photoluminescence. Lasers Surg Med 2010; 42: 630-639.